Published in Acta Neuropathol on February 03, 2017
Current Understanding of Neurodegenerative Diseases Associated With the Protein Tau. Mayo Clin Proc (2017) 0.75
Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcripts. Science (2016) 1.43
Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies. Hum Mol Genet (2014) 1.40
[18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration. Acta Neuropathol (2016) 0.95
Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers. Neurobiol Aging (2014) 0.94
Late-onset Alzheimer's risk variants in memory decline, incident mild cognitive impairment, and Alzheimer's disease. Neurobiol Aging (2014) 0.93
Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies. Neurobiol Aging (2014) 0.89
Defining imaging biomarker cut points for brain aging and Alzheimer's disease. Alzheimers Dement (2016) 0.89
Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol (2015) 0.87
Age-related decline in white matter integrity in a mouse model of tauopathy: an in vivo diffusion tensor magnetic resonance imaging study. Neurobiol Aging (2013) 0.84
Performance of the CogState computerized battery in the Mayo Clinic Study on Aging. Alzheimers Dement (2015) 0.83
Levels of tau protein in plasma are associated with neurodegeneration and cognitive function in a population-based elderly cohort. Alzheimers Dement (2016) 0.82
Evaluating pathogenic dementia variants in posterior cortical atrophy. Neurobiol Aging (2015) 0.80
Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging. Alzheimers Dement (2014) 0.80
Influence of amyloid and APOE on cognitive performance in a late middle-aged cohort. Alzheimers Dement (2015) 0.80
Mediterranean diet, micronutrients and macronutrients, and MRI measures of cortical thickness. Alzheimers Dement (2016) 0.80
Insights into the pathogenic mechanisms of Chromosome 9 open reading frame 72 (C9orf72) repeat expansions. J Neurochem (2016) 0.78
Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease. Alzheimers Dement (2016) 0.78
TYROBP genetic variants in early-onset Alzheimer's disease. Neurobiol Aging (2016) 0.78
TDP-1, the Caenorhabditis elegans ortholog of TDP-43, limits the accumulation of double-stranded RNA. EMBO J (2014) 0.77
C9orf72 promoter hypermethylation is reduced while hydroxymethylation is acquired during reprogramming of ALS patient cells. Exp Neurol (2015) 0.77
microRNA profiling: increased expression of miR-147a and miR-518e in progressive supranuclear palsy (PSP). Neurogenetics (2016) 0.76
RAB39B gene mutations are not a common cause of Parkinson's disease or dementia with Lewy bodies. Neurobiol Aging (2016) 0.76
Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies. Neurobiol Aging (2016) 0.75
Neuropathologic differences by race from the National Alzheimer's Coordinating Center. Alzheimers Dement (2016) 0.75
Imaging markers of cerebrovascular pathologies: Pathophysiology, clinical presentation, and risk factors. Alzheimers Dement (Amst) (2016) 0.75
MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies. Alzheimers Dement (2016) 0.75
Comparison of Gait Parameters for Predicting Cognitive Decline: The Mayo Clinic Study of Aging. J Alzheimers Dis (2016) 0.75
An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease. Alzheimers Dement (2016) 0.75
Brain tau deposition linked to systemic causes of death in normal elderly. Neurobiol Aging (2016) 0.75
Mutant TDP-43 does not impair mitochondrial bioenergetics in vitro and in vivo. Mol Neurodegener (2017) 0.75
Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study. Lancet Neurol (2017) 0.75
Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia. Brain (2017) 0.75
Ioflupane 123I (DAT scan) SPECT identifies dopamine receptor dysfunction early in the disease course in progressive apraxia of speech. J Neurol (2020) 0.75
Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study. Lancet Neurol (2017) 0.75
Pittsburgh compound B (PiB) PET imaging of meningioma and other intracranial tumors. J Neurooncol (2017) 0.75
Neurocognition in individuals with incidentally-identified meningioma. J Neurooncol (2017) 0.75
Pick's disease: clinicopathologic characterization of 21 cases. J Neurol (2020) 0.75
The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes. Brain (2019) 0.75
DCTN1 variation in pathologically-confirmed PSP and CBD tauopathy. Parkinsonism Relat Disord (2017) 0.75
LRP10 variants in progressive supranuclear palsy. Neurobiol Aging (2020) 0.75
Proximity proteomics of C9orf72 dipeptide repeat proteins identifies molecular chaperones as modifiers of poly-GA aggregation. Acta Neuropathol Commun (2022) 0.75